Financial Performance - Net sales decreased by $0.9 million, or 11%, to $6.95 million for the three months ended September 30, 2025, compared to $7.87 million for the same period in 2024[73] - For the nine months ended September 30, 2025, net sales totaled $20,578,717, a decrease from $21,128,263 in the same period of 2024[74] - Net sales decreased by approximately $0.5 million, or 3%, to $20.6 million for the nine months ended September 30, 2025, compared to $21.1 million for the same period in 2024[76] Profitability - Gross profit for the three months ended September 30, 2025, was $854,359, representing 12% of net sales, down from $1,833,720, or 23% of net sales, in the prior year[73] - Gross profit decreased by 54%, to $0.9 million for the three months ended September 30, 2025, compared to $1.8 million for the same period in 2024[78] - Gross profit for the nine months ended September 30, 2025, was $4,760,943, representing 23% of net sales, compared to 22% in the prior year[74] Expenses - General and administrative expenses increased to $2,072,962, accounting for 30% of net sales, compared to 22% in the same period last year[73] - General and administrative expenses increased by $0.3 million, or 20%, to $2.1 million for the three months ended September 30, 2025, compared to $1.7 million for the same period in 2024[79] - Cost of revenue increased by $0.1 million to $6.1 million for the three months ended September 30, 2025, compared to $6.0 million for the same period in 2024[77] Net Loss - The net loss for the three months ended September 30, 2025, was $1,429,133, or 21% of net sales, compared to a net loss of $13,289, or 0% of net sales, in the prior year[73] - Net loss increased by $1.4 million to $1.4 million for the three months ended September 30, 2025, compared to a net income of $0.0 million for the same period in 2024[82] - For the nine months ended September 30, 2025, net loss increased by $0.5 million to $1.4 million compared to a net loss of $0.9 million in 2024[83] Cash Flow - Net cash provided by operating activities was $676,529 for the nine months ended September 30, 2025, compared to a net cash used of $1,566,598 for the same period in 2024[105] - Net cash used in investing activities increased to $643,808 for the nine months ended September 30, 2025, from $319,229 in 2024, primarily due to a one-time asset disposal in 2024[107] - Net cash used in financing activities was $53,584 for the nine months ended September 30, 2025, compared to net cash provided of $204,366 in 2024, driven by a decrease in debt borrowings of $600,000[108] Financing and Compliance - As of September 30, 2025, the company had cash totaling $0.6 million and a line of credit with $0.7 million available[99] - As of September 30, 2025, the Company was not in compliance with financial covenants, but received a waiver from M&T Bank, requiring repayment of approximately $1.3 million in loans and reducing the revolving credit line from $8.0 million to $7.5 million[101] - The Company obtained approximately $1.5 million in financing from a related party to facilitate required paydowns under the waiver[102] - The Company expects to maintain compliance with all amended covenants through the remainder of 2025, strengthening its liquidity position[103] Market and Operational Developments - The company plans to grow into new end markets of communications and sensing, having entered the communications market in 2023[59] - In 2023, the company launched several new products, including low weight night vision optics and biomedical mirrors for the medical end market[55] - The company has increased its inventory of key raw materials to mitigate supply chain disruptions, resulting in higher prepaid inventory compared to prior periods[60] - The company operates a nearly 90,000 square foot facility in Rochester, New York, which allows for increased production capacity and advanced manufacturing processes[53] Risks - Significant risks affecting liquidity include economic consequences of global pandemics, geopolitical conflicts, and supply chain disruptions[104] - The primary market risk exposure for the Company is interest rate sensitivity, with no material changes reported during the nine months ended September 30, 2025[109]

[Filing Information](index=1&type=section&id=Filing%20Information) This section provides essential identification details for the registrant, SYNTEC OPTICS HOLDINGS, INC., and specifics of the Form 8-K filing, including its jurisdiction, address, and report dates [Registrant and Filing Details](index=1&type=section&id=Registrant%20and%20Filing%20Details) This section provides the core identification details for the registrant, SYNTEC OPTICS HOLDINGS, INC., and the specifics of the Form 8-K filing, including its jurisdiction, address, and the date of the report - The registrant is **SYNTEC OPTICS HOLDINGS, INC.**, incorporated in Delaware, with principal executive offices at 515 Lee Rd., Rochester, NY 14606[1](index=1&type=chunk)[2](index=2&type=chunk) - The Form 8-K report date is **October 6, 2025**, with the earliest event reported on **October 3, 2025**[1](index=1&type=chunk) [Securities Information](index=1&type=section&id=Securities%20Information) This part details the securities registered by SYNTEC OPTICS HOLDINGS, INC. under Section 12(b) of the Securities Exchange Act of 1934, including their trading symbols and the exchange on which they are registered Securities Registered Under Section 12(b) | Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | | :------------------ | :---------------- | :---------------------------------------- | | Common stock, par value $0.0001 per share | OPTX | The Nasdaq Capital Market | | Redeemable warrants, exercisable for common stock at an exercise price of $11.50 per share, subject to adjustment | OPTXW | The Nasdaq Capital Market | [Emerging Growth Company Status](index=1&type=section&id=Emerging%20Growth%20Company%20Status) The company has indicated its status as an 'emerging growth company' as defined by relevant SEC rules - **SYNTEC OPTICS HOLDINGS, INC.** is designated as an 'Emerging growth company'[3](index=3&type=chunk) [Item 2.02 Results of Operations and Financial Condition](index=2&type=section&id=Item%202.02%20Results%20of%20Operations%20and%20Financial%20Condition) This section details the company's announcement of financial results for specific quarters and the full year through a press release [Financial Results Announcement](index=2&type=section&id=Financial%20Results%20Announcement) SYNTEC OPTICS HOLDINGS, INC. announced its financial results for the fourth quarter and full year ended December 31, 2024, and the first and second quarters of 2025, through a press release - On **October 6, 2025**, the Company issued a press release announcing financial results for **Q4 2024, Q1 2025, and Q2 2025**[4](index=4&type=chunk) - The press release is attached as **Exhibit 99.1** and is furnished under Item 2.02, not deemed 'filed' for Section 18 purposes unless specifically referenced[4](index=4&type=chunk)[5](index=5&type=chunk) [Item 9.01 Financial Statement and Exhibits](index=2&type=section&id=Item%209.01%20Financial%20Statement%20and%20Exhibits) This section provides a comprehensive list of all documents filed as exhibits to the Form 8-K, including the financial results press release and interactive data [Exhibits List](index=2&type=section&id=Exhibits%20List) This section lists the documents filed as exhibits to the Form 8-K, including the press release detailing financial results and the interactive data file Exhibits Filed | Exhibit Number | Description | | :------------- | :---------- | | 99.1 | Press release dated October 6, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | [Signatures](index=3&type=section&id=SIGNATURES) This section confirms the official signing of the report by the registrant's authorized officer, validating its submission [Report Signatures](index=3&type=section&id=Report%20Signatures) The report is officially signed by the registrant's authorized officer, confirming its submission in accordance with the Securities Exchange Act of 1934 - The report was signed on behalf of **SYNTEC OPTICS HOLDINGS, INC.** by **Al Kapoor, Chief Executive Officer**, on **October 6, 2025**[8](index=8&type=chunk)[9](index=9&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41034 SYNTEC OPTICS HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 87-0816957 | | --- | --- | | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41034 Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s) | Name of each exchange on wh ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Exact Name of Registrant as Specified in Its Charter) (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41034 SYNTEC OPTICS HOLDINGS, INC. | Title of each class | Trading Symbol(s) | Na ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 001-41034 SYNTEC OPTICS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0816957 (State or other jurisdicti ...

(MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarter ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41034 OMNILIT ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 87-0816957 | | --- | --- | | (St ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41034 OMNILIT ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 87-0816957 | | --- | --- | | (State o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41034 OMNILIT ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Indicate by check mark whether the registrant is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to ________________ Commission file number: 001-41034 OMNILIT ACQUISITION CORP. (Exact name of registrant as specified in its charter) | Delaware | 87-0816 ...